Genesis Biopharma, a biotechnology company developing targeted cancer therapies, has named Michael Handelman as chief financial officer (CFO), treasurer and secretary, succeeding Richard McKilligan.
Handelman currently serves as the CFO of Oxis International. Before joining Oxis, he served as CFO and chief operating officer (COO) of TechnoConcepts, a developing technology and manufacturing company. Prior to that, he was CFO of Interglobal Waste Management, a start-up manufacturing company. Handelman has also been CFO of the Los Angeles Kings, a National Hockey League franchise. He is a certified public accountant (CPA) and holds a degree in accounting from the City University of New York.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more